Send to

Choose Destination
Surgery. 2002 Oct;132(4):724-7; discussion 727-8.

Long-term data indicate a progressive loss in efficacy of adjustable silicone gastric banding for the surgical treatment of morbid obesity.

Author information

Department of Surgery, College of Medicine, University of Iowa, Iowa City, Iowa 52242-1086, USA.



Many short-term follow-up reports on the efficacy of the adjustable silicone gastric band (ASGB) and its modification for laparoscopic insertion (Lap-Band) for the surgical treatment of morbid obesity have been reported in the surgical literature. However, long-term studies are lacking.


Between March 17, 1992, and January 7, 1997, 45 females and 17 males consecutively entered this prospective study. Forty ASGB and 22 Lap-Band were implanted. Mean age was 34 years (range 19-51); mean height was 171 cm (range 152-190); mean weight was 145 kg (range 100-214). Weight loss and adverse events associated with the device were observed over time.


There was no operative mortality. Thirty intra-abdominal reoperations were necessary to correct complications related to the implanted ASGB and the Lap-Band. In the ASGB cohort, the body mass index (BMI) decreased from 50 to 36 over a 3-year period and then increased to 44 at 8 years after operation. In the Lap-Band cohort the BMI decreased from 47 to 40 at 1 year and then increased to 43 at 6 years after operation. Twenty-seven implantable devices (18 ASGB, 9 Lap-Band) have been removed to date.


The results of this study do not support the use of ASGB devices for the surgical treatment of morbid obesity. The Lap-Band is less effective than ASGB.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center